The Analysts’ Updated EPS Estimates for October, 7th (AAOI, ALXN, BGNE, BIIB, BOFI, CASH, CATM, FN, FNSR, GOOGL)

The Analysts’ Updated EPS Estimates for October, 7th (AAOI, ALXN, BGNE, BIIB, BOFI, CASH, CATM, FN, FNSR, GOOGL)

Analysts’ updated eps estimates for Friday, October 7th:

Applied Optoelectronics (NASDAQ:AAOI) had its overweight rating reissued by analysts at Piper Jaffray Cos.. The firm currently has a $27.00 target price on the stock, up from their previous target price of $24.00.

Alexion Pharmaceuticals (NASDAQ:ALXN) had its sell rating reaffirmed by analysts at FBR & Co.

10/07/analysts-updated-eps-estimates-for-october-7th-aaoi-alxn-bgne-biib-bofi-cash-catm-fn-fnsr-googl.html

BeiGene (NASDAQ:BGNE) had its buy rating reiterated by analysts at Cowen and Company. The analysts wrote, “BeiGene reported positive Phase I data in Waldenstrom’s Macroglobulinemia (WM) for.””

Biogen (NASDAQ:BIIB) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $386.00 target price on the stock.

BofI Holding (NASDAQ:BOFI) had its buy rating reissued by analysts at FBR & Co.

Meta Financial Group (NASDAQ:CASH) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. The firm currently has $75.00 price target on the stock. According to Zacks, “Meta Financial Group, Inc. is the holding company for federally chartered savings bank MetaBank, Member FDIC. Headquartered in Sioux Falls, S.D., MetaBank operates in both the Banking and Payments industries: MetaBank, its retail banking division; Meta Payment Systems, its electronic payments division; AFS/IBEX, its insurance premium finance division; and Refund Advantage, its tax refund-transfer software division. The synergies among the four provide a unique business model for the company. “

Cardtronics (NASDAQ:CATM) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Cardtronics plc provides ATM services primarily in North America and Europe. The company is at the convergence of retailers, financial institutions, prepaid card programs and the customers they share. Cardtronics, Inc., formerly known as Cardtronics plc, is headquartered in Houston, Texas. “

Fabrinet (NYSE:FN) had its overweight rating reaffirmed by analysts at Piper Jaffray Cos.. They currently have a $53.00 target price on the stock, up from their previous target price of $50.00.

Finisar Corp. (NASDAQ:FNSR) had its overweight rating reiterated by analysts at Piper Jaffray Cos.. They currently have a $38.00 target price on the stock, up from their previous target price of $31.00.

Alphabet (NASDAQ:GOOGL) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $900.00 target price on the stock.

Gap (NYSE:GPS) had its hold rating reiterated by analysts at FBR & Co. The firm currently has a $22.00 target price on the stock.

Honeywell International (NYSE:HON) had its buy rating reiterated by analysts at Bank of America Corp.. They currently have a $125.00 target price on the stock.

Independent Contract Drilling (NYSE:ICD) had its buy rating reaffirmed by analysts at FBR & Co.

Idera Pharmaceuticals (NASDAQ:IDRA) had its target price increased by S&P Equity Research from $1.86 to $2.10.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) had its outperform rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $195.00 target price on the stock.

Kite Pharma (NASDAQ:KITE) had its buy rating reaffirmed by analysts at Canaccord Genuity. The analysts wrote, “BeiGene presented updated clinical data for its BTK inhibitor BGB-3111 in patients with Waldenström’s Macroglobulinemia (WM) at the International Workshop on Waldenström’s Macroglobulinemia and Symposium on Advances in Multiple Myeloma (IWWM-9) in Amsterdam, the Netherlands.””

Karyopharm Therapeutics (NASDAQ:KPTI) had its outperform rating reiterated by analysts at Leerink Swann. They currently have a $18.00 price target on the stock.

Lumentum Holdings (NASDAQ:LITE) had its overweight rating reaffirmed by analysts at Piper Jaffray Cos.. Piper Jaffray Cos. currently has a $47.00 price target on the stock, up from their previous price target of $38.00.

Micron Technology (NASDAQ:MU) had its underperform rating reaffirmed by analysts at Needham & Company LLC.

NeoPhotonics Corp. (NYSE:NPTN) had its overweight rating reiterated by analysts at Piper Jaffray Cos.. They currently have a $20.00 price target on the stock, up from their previous price target of $17.00.

Oclaro (NASDAQ:OCLR) had its overweight rating reaffirmed by analysts at Piper Jaffray Cos.. The firm currently has a $10.50 price target on the stock, up from their previous price target of $9.00.

Related posts

Leave a Comment